State Of Tennessee, Treasury Department Eli Lilly & CO Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Eli Lilly & CO stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 298,668 shares of LLY stock, worth $223 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

298,668

Previous 309,621 3.54%

Holding current value

$223 Million

Previous $280 Million 5.61%

% of portfolio

0.95%

Previous 1.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $8.46 Million - $10.5 Million	-10,953 Reduced 3.54%	298,668 $265 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $4.93 Million - $6.18 Million	-6,800 Reduced 2.15%	309,621 $280 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $7.51 Million - $10 Million	-12,683 Reduced 3.85%	316,421 $246 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $61.6 Million - $72.6 Million	117,238 Added 55.34%	329,104 $192 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $55 Million - $73.6 Million	-156,918 Reduced 42.55%	211,866 $99.4 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $454,451 - $533,731	-1,463 Reduced 0.4%	368,784 $127 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $2.1 Million - $2.45 Million	-6,541 Reduced 1.74%	370,247 $135 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $13.7 Million - $16.1 Million	-49,281 Reduced 11.57%	376,788 $122 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $10.9 Million - $13.6 Million	-46,583 Reduced 9.86%	426,069 $122 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $21.1 Million - $26.2 Million	93,862 Added 24.78%	472,652 $131 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $2.88 Million - $3.54 Million	-12,991 Reduced 3.32%	378,790 $87.5 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $23.8 Million - $30.8 Million	-132,084 Reduced 25.21%	391,781 $89.9 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $32.9 Million - $42.6 Million	-200,234 Reduced 27.65%	523,865 $97.9 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $28.3 Million - $37.5 Million	-217,135 Reduced 23.07%	724,099 $122 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $59.5 Million - $68.8 Million	406,948 Added 76.17%	941,234 $139 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $16.8 Million - $20.2 Million	-123,142 Reduced 18.73%	534,286 $87.7 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $5.09 Million - $6.3 Million	42,762 Added 6.96%	657,428 $91.2 Million
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $7.64 Million - $9.47 Million	-71,493 Reduced 10.42%	614,666 $80.8 Million
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $663,913 - $722,166	6,217 Added 0.91%	686,159 $76.7 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $41.8 Million - $48.8 Million	377,142 Added 124.55%	679,942 $75.3 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $4.07 Million - $4.8 Million	-36,605 Reduced 10.79%	302,800 $39.3 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $2.4 Million - $2.69 Million	22,652 Added 7.15%	339,405 $39.3 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $43.4 Million - $54.3 Million	-506,004 Reduced 61.5%	316,753 $34 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $11.9 Million - $13.7 Million	157,161 Added 23.61%	822,757 $70.2 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $8.52 Million - $10.1 Million	114,752 Added 20.83%	665,596 $51.5 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $13.3 Million - $14.2 Million	-161,974 Reduced 22.72%	550,844 $46.5 Million
Q3 2017 Nov 01, 2017	BUY	$77.07 - $85.54 $54.9 Million - $61 Million	712,818	712,818 $61 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Eli Lilly & CO Transaction History